IL SB2917

Amends the Epinephrine Auto-Injector Act to provide liability protections for authorized entities, their employees and agents, and healthcare providers who administer epinephrine auto-injectors in good faith, except in cases of willful and wanton conduct.

Allows trained employees or agents of authorized entities to provide or administer epinephrine auto-injectors to any individual on the property whom they believe in good faith is experiencing anaphylaxis, regardless of prior diagnosis or prescription.

Requires employees, agents, or other individuals to complete anaphylaxis training from a nationally recognized organization before administering epinephrine auto-injectors; training is valid for 2 years and can be conducted online or in person.

Mandates training include recognition of allergic reactions and anaphylaxis, administration procedures, and competency testing; optional training may cover high-risk areas, allergen prevention, and emergency follow-up procedures.

Protects healthcare professionals from civil or professional liability for declining to provide epinephrine auto-injector standing orders or prescriptions.